Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by beta-glucans in vitro

被引:59
作者
Ohno, N [1 ]
Hashimoto, T [1 ]
Adachi, Y [1 ]
Yadomae, T [1 ]
机构
[1] TOKYO UNIV PHARM & LIFE SCI,LAB IMMUNOPHARMACOL MICROBIAL PROD,HACHIOJI,TOKYO 19203,JAPAN
关键词
beta-glucan; nitric oxide; IFN-gamma; macrophage; sonifilan; single helix;
D O I
10.1016/0165-2478(96)02538-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have already demonstrated that various activities including NO (nitric oxide) synthesis in vivo were significantly different between triple helical (SPG) and single helical (alkaline-treated SPG, SPG-OH) beta-glucans, and that beta-glucan-mediated NO synthesis was associated with increased gene expression of IFN-gamma. In this study, we analyzed beta-glucan-mediated NO production in vitro with the concomitant use of IFN-gamma. Proteose peptone-elicited peritoneal macrophages (PM) were collected from male C3H/HeJ mice and cultured with beta-glucans in the presence or absence of IFN-gamma for 24 h. It was found that SPG-OH, but not SPG, enhanced NO synthesis in vitro, especially in the presence of IFN-gamma. Concentrations of interleukin-1 alpha, -6 and TNF-alpha in the culture supernatant of SPG-OH were significantly higher than those in that of SPG. Membrane-associated IL-1 alpha was also high with SPG-OH. Cytokine productivity of PMs, as well as NO synthesis, was elevated in the presence of IFN-gamma. These facts intensely suggest that the single helical conformer of beta-glucan (SPG-OH) is dominant in cytokine production and subsequent NO synthesis.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 22 条
[1]  
ADACHI Y, 1990, CHEM PHARM BULL, V38, P988
[2]  
Akiyama Y, 1981, Tanpakushitsu Kakusan Koso, V26, P208
[3]  
DING AH, 1988, J IMMUNOL, V141, P2407
[4]   INTERFERON-GAMMA AND TUMOR NECROSIS FACTOR INDUCE THE L-ARGININE-DEPENDENT CYTO-TOXIC EFFECTOR MECHANISM IN MURINE MACROPHAGES [J].
DRAPIER, JC ;
WIETZERBIN, J ;
HIBBS, JB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1587-1592
[5]  
FUJIMOTO S, 1988, BIOTHERAPY, V2, P500
[6]  
LORSBACH RB, 1993, J BIOL CHEM, V268, P1908
[7]  
MIURA H, 1995, BIOL PHARM BULL, V18, P1797
[8]  
MONADA S, 1989, BIOCHEM PHARMACOL, V38, P1709
[9]  
NAGI N, 1993, BIOL PHARM BULL, V16, P822
[10]  
OHNO N, 1995, BIOL PHARM BULL, V18, P1242